Back to MORGAN STANLEY MORGAN STANLEY

BBNXBBNX
6 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in BETA BIONICS INC

Yes. Morgan Stanley holds 4,266,822 shares of BBNX (Beta Bionics), worth $66.9M, as of its Q2 2026 13F filing. It increased the position by 39,188 shares (+0.9%) from Q1 2026. Morgan Stanley has held BBNX in every 13F on record since Q1 2025, 6 quarterly filings.

Current Value

$66.9M

Current Shares

4.3M

Total Value Change

+$49.7M

Total Shares Change

+2.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
4.3M
+0.9%
$66.9M0.0%$15.67
30
2026-Q1
Increased
4.2M
+22.2%
$42.4M0.0%$11.57
35
2025-Q4
Decreased
3.5M
-8.0%
$105.4M0.0%$31.97
0
2025-Q3
Increased
3.8M
+27.5%
$74.7M0.0%$19.85
37
2025-Q2
Increased
2.9M
+110.4%
$42.9M0.0%$15.07
47
2025-Q1
New
1.4M
-
$17.2M0.0%$11.71
39

Other major holders of BBNX: FARALLON CAPITAL MANAGEMENT, L.L.C., BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP, RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used